AAAAAA

   
Results: 1-20 |
Results: 20
PRESENCE AND CHARACTERISTICS OF RECEPTORS FOR [D-TRP(6)]LUTEINIZING HORMONE-RELEASING HORMONE AND EPIDERMAL GROWTH-FACTOR IN HUMAN OVARIAN-CANCER
Authors: SRKALOVIC G SCHALLY AV WITTLIFF JL DAY TG JENISON EL
Citation: G. Srkalovic et al., PRESENCE AND CHARACTERISTICS OF RECEPTORS FOR [D-TRP(6)]LUTEINIZING HORMONE-RELEASING HORMONE AND EPIDERMAL GROWTH-FACTOR IN HUMAN OVARIAN-CANCER, International journal of oncology, 12(3), 1998, pp. 489-498
A NOVEL-APPROACH FOR COMPARING LIGAND-BINDING RESULTS FROM TITRATION AND COMPETITION ANALYSES TO STUDY HORMONE MIMICS
Authors: RAFFELSBERGER W WITTLIFF JL
Citation: W. Raffelsberger et Jl. Wittliff, A NOVEL-APPROACH FOR COMPARING LIGAND-BINDING RESULTS FROM TITRATION AND COMPETITION ANALYSES TO STUDY HORMONE MIMICS, Journal of clinical ligand assay, 20(4), 1997, pp. 275-280
DOES MENOPAUSAL STATUS INFLUENCE SEX-STEROID RECEPTOR CONTENT AND SPECIFIC-BINDING CAPACITY
Authors: WITTLIFF JL MISELJIC S CUMMINS JA PASIC R
Citation: Jl. Wittliff et al., DOES MENOPAUSAL STATUS INFLUENCE SEX-STEROID RECEPTOR CONTENT AND SPECIFIC-BINDING CAPACITY, Journal of clinical ligand assay, 19(3), 1996, pp. 203-207
EXPRESSION OF HEAT-SHOCK PROTEINS IN HUMAN BREAST, ENDOMETRIAL AND OVARIAN CARCINOMAS
Authors: WITTLIFF JL REISS RG EICHENBERGER MR DOERING DL
Citation: Jl. Wittliff et al., EXPRESSION OF HEAT-SHOCK PROTEINS IN HUMAN BREAST, ENDOMETRIAL AND OVARIAN CARCINOMAS, Clinical chemistry, 42(6), 1996, pp. 687-687
QUANTITATIVE-ANALYSES OF EPIDERMAL GROWTH-FACTOR RECEPTORS, HER-2 NEUONCOPROTEIN AND CATHEPSIN-D IN NONMALIGNANT AND MALIGNANT UTERI/
Authors: SANFILIPPO JS MISELJIC S YANG AR DOERING DL SHAHEEN RM WITTLIFF JL
Citation: Js. Sanfilippo et al., QUANTITATIVE-ANALYSES OF EPIDERMAL GROWTH-FACTOR RECEPTORS, HER-2 NEUONCOPROTEIN AND CATHEPSIN-D IN NONMALIGNANT AND MALIGNANT UTERI/, Cancer, 77(4), 1996, pp. 710-716
MECHANISMS OF SIGNAL-TRANSDUCTION - SEX-HORMONES, THEIR RECEPTORS ANDCLINICAL UTILITY
Authors: WITTLIFF JL RAFFELSBERGER W
Citation: Jl. Wittliff et W. Raffelsberger, MECHANISMS OF SIGNAL-TRANSDUCTION - SEX-HORMONES, THEIR RECEPTORS ANDCLINICAL UTILITY, Journal of clinical ligand assay, 18(4), 1995, pp. 211-235
MENOPAUSAL INFLUENCE ON EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTORS, HER-S NEU ONCOPROTEIN, AND CATHEPSIN-D IN BREAST-CANCER/
Authors: MISELJIC S CAVAZOS AS WITTLIFF JL
Citation: S. Miseljic et al., MENOPAUSAL INFLUENCE ON EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTORS, HER-S NEU ONCOPROTEIN, AND CATHEPSIN-D IN BREAST-CANCER/, Journal of clinical ligand assay, 18(3), 1995, pp. 176-180
PROTEIN MARKERS FOR MALIGNANT TRANSFORMATION OF THE COLON
Authors: MISELJIC S GALANDIUK S YANG AR FIECHTER J WITTLIFF JL
Citation: S. Miseljic et al., PROTEIN MARKERS FOR MALIGNANT TRANSFORMATION OF THE COLON, Journal of clinical ligand assay, 18(2), 1995, pp. 135-140
COMPARISON OF CATHEPSIN-D DETERMINATIONS IN HUMAN CARCINOMAS BY ENZYME-IMMUNOASSAY AND IMMUNORADIOMETRIC ASSAY
Authors: SHAHEEN RM MISELJIC S DOERING DL WITTLIFF JL
Citation: Rm. Shaheen et al., COMPARISON OF CATHEPSIN-D DETERMINATIONS IN HUMAN CARCINOMAS BY ENZYME-IMMUNOASSAY AND IMMUNORADIOMETRIC ASSAY, Journal of clinical laboratory analysis, 9(6), 1995, pp. 351-358
EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN COLON-DISEASE
Authors: MISELJIC S GALANDIUK S MYERS SD WITTLIFF JL
Citation: S. Miseljic et al., EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR IN COLON-DISEASE, Journal of clinical laboratory analysis, 9(6), 1995, pp. 413-417
AGREEMENT OF EGF RECEPTOR DETERMINATIONS BY IMMUNOHISTOCHEMISTRY AND RADIOLIGAND-BINDING
Authors: SEWELL CL MARTIN AW MISELJIC S WITTLIFF JL
Citation: Cl. Sewell et al., AGREEMENT OF EGF RECEPTOR DETERMINATIONS BY IMMUNOHISTOCHEMISTRY AND RADIOLIGAND-BINDING, Laboratory investigation, 72(1), 1995, pp. 141-141
UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAL-1) EXPRESSION IN COLON DISEASES
Authors: MISELJIC S GALANDIUK S MYERS SD WITTLIFF JL
Citation: S. Miseljic et al., UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAL-1) EXPRESSION IN COLON DISEASES, Clinical chemistry, 41(6), 1995, pp. 224-224
RELATION BETWEEN CATHEPSIN-D EXPRESSION AND OTHER PROGNOSTIC FACTORS IN BREAST CARCINOMAS
Authors: SHAHEEN RM MISELJIC S WIEHLE RD WITTLIFF JL
Citation: Rm. Shaheen et al., RELATION BETWEEN CATHEPSIN-D EXPRESSION AND OTHER PROGNOSTIC FACTORS IN BREAST CARCINOMAS, Clinical chemistry, 41(11), 1995, pp. 1585-1591
CHARACTERIZATION OF BOMBESIN GASTRIN-RELEASING PEPTIDE RECEPTORS IN HUMAN BREAST-CANCER AND THEIR RELATIONSHIP TO STEROID-RECEPTOR EXPRESSION
Authors: HALMOS G WITTLIFF JL SCHALLY AV
Citation: G. Halmos et al., CHARACTERIZATION OF BOMBESIN GASTRIN-RELEASING PEPTIDE RECEPTORS IN HUMAN BREAST-CANCER AND THEIR RELATIONSHIP TO STEROID-RECEPTOR EXPRESSION, Cancer research, 55(2), 1995, pp. 280-287
DETECTION OF CATHEPSIN-D IN INFILTRATING DUCT BREAST-CARCINOMA - IMMUNOHISTOCHEMISTRY VERSUS ENZYME-IMMUNOASSAY
Authors: THEUER HH LEAR SC MARTIN AW MISELJIC S WITTLIFF JL
Citation: Hh. Theuer et al., DETECTION OF CATHEPSIN-D IN INFILTRATING DUCT BREAST-CARCINOMA - IMMUNOHISTOCHEMISTRY VERSUS ENZYME-IMMUNOASSAY, Laboratory investigation, 70(1), 1994, pp. 10000023-10000023
ESTROGEN-BINDING BY CHRF-288-11 MEGAKARYOCYTES IN CULTURE AND ITS INFLUENCE ON THE COLLAGEN RECEPTOR INTEGRIN ALPHA-2-BETA-1
Authors: TARANTINO MD YANG AR NUGENT DJ KUNICKI TJ PEIPER SC WITTLIFF JL
Citation: Md. Tarantino et al., ESTROGEN-BINDING BY CHRF-288-11 MEGAKARYOCYTES IN CULTURE AND ITS INFLUENCE ON THE COLLAGEN RECEPTOR INTEGRIN ALPHA-2-BETA-1, Blood, 84(10), 1994, pp. 10000692-10000692
INHIBITION OF GROWTH OF THE HUMAN-MALIGNANT GLIOMA CELL-LINE (U87MG) BY THE STEROID-HORMONE ANTAGONIST RU486
Authors: PINSKI J HALMOS G SHIRAHIGE Y WITTLIFF JL SCHALLY AV
Citation: J. Pinski et al., INHIBITION OF GROWTH OF THE HUMAN-MALIGNANT GLIOMA CELL-LINE (U87MG) BY THE STEROID-HORMONE ANTAGONIST RU486, The Journal of clinical endocrinology and metabolism, 77(5), 1993, pp. 1388-1392
EXPRESSION OF CATHEPSIN-D IN HUMAN ENDOMETRIAL AND OVARIAN CARCINOMAS
Authors: SHAHEEN RM MISELJIC S WITTLIFF JL
Citation: Rm. Shaheen et al., EXPRESSION OF CATHEPSIN-D IN HUMAN ENDOMETRIAL AND OVARIAN CARCINOMAS, Clinical research, 41(3), 1993, pp. 10000710-10000710
BROMODEOXYURIDINE LABELING FOR S-PHASE MEASUREMENT IN BREAST-CARCINOMA
Authors: MEYER JS KOEHM SL HUGHES JM HIGA E WITTLIFF JL LAGOS JA MANES JL
Citation: Js. Meyer et al., BROMODEOXYURIDINE LABELING FOR S-PHASE MEASUREMENT IN BREAST-CARCINOMA, Cancer, 71(11), 1993, pp. 3531-3540
EXPRESSION OF HORMONE RECEPTORS, CATHEPSIN-D, AND HER-2 NEU ONCOPROTEIN IN NORMAL COLON AND COLONIC DISEASE/
Authors: GALANDIUK S MISELJIC S YANG AR EARLY M MCCOY MD WITTLIFF JL
Citation: S. Galandiuk et al., EXPRESSION OF HORMONE RECEPTORS, CATHEPSIN-D, AND HER-2 NEU ONCOPROTEIN IN NORMAL COLON AND COLONIC DISEASE/, Archives of surgery, 128(6), 1993, pp. 637-642
Risultati: 1-20 |